Only one or two of every 10,000 promising substances will successfully pass extensive testing in the research and development phase to be approved as a marketable drug.
The estimated cost of developing a new medicine is £560 million. This takes approximately 15 years from laboratory to licence (passing through pre-clinical, clinical and regulatory approval phases).
There is still no adequate therapy for three-quarters of the 2,500 medical conditions currently recognised.